SRE
Tiny tweak, same message
JPMorgan didn’t exactly drop a bombshell on Sempra. It nudged the price target up to $107 from $106 and left the Overweight rating untouched — the financial equivalent of moving the couch one inch to the left and calling it a renovation.
Why you should care
On one hand, this is not the kind of analyst call that sends traders sprinting for the exits or the buy button. On the other, it matters because it reinforces the idea that big banks still see value in Sempra’s setup, even after a stock that’s already been grinding around in the utilities lane.
The analyst tape is getting crowded
JPMorgan’s note lands just after a handful of other firms have been tinkering with Sempra too:
- Jefferies lifted its target to $100 and kept Hold
- Barclays bumped its target to $105 and stayed Overweight
- Evercore ISI had already moved to $107 with Outperform
So this is less “new story” and more “the Street is slowly inching higher on the name.” In other words, nobody seems to hate the stock — they just keep adjusting the thermostat by a degree or two.
Big picture
For Sempra, the important part isn’t the one-dollar move. It’s that analysts continue to treat it like a steady utility with some upside, not a broken thesis. If you own it, this is a mild confidence check, not a victory lap.